These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16238097)

  • 1. F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement.
    Aguilar L; Ramírez G; Valck C; Molina MC; Rojas A; Schwaeble W; Ferreira V; Ferreira A
    Biol Res; 2005; 38(2-3):187-95. PubMed ID: 16238097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta.
    Castillo C; Ramírez G; Valck C; Aguilar L; Maldonado I; Rosas C; Galanti N; Kemmerling U; Ferreira A
    PLoS Negl Trop Dis; 2013; 7(8):e2376. PubMed ID: 23991234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity.
    Ramírez G; Valck C; Molina MC; Ribeiro CH; López N; Sánchez G; Ferreira VP; Billetta R; Aguilar L; Maldonado I; Cattán P; Schwaeble W; Ferreira A
    Immunobiology; 2011; 216(1-2):265-73. PubMed ID: 20472323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi.
    Ferreira V; Valck C; Sánchez G; Gingras A; Tzima S; Molina MC; Sim R; Schwaeble W; Ferreira A
    J Immunol; 2004 Mar; 172(5):3042-50. PubMed ID: 14978109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin.
    Sosoniuk E; Vallejos G; Kenawy H; Gaboriaud C; Thielens N; Fujita T; Schwaeble W; Ferreira A; Valck C
    Mol Immunol; 2014 Jul; 60(1):80-5. PubMed ID: 24769495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does native Trypanosoma cruzi calreticulin mediate growth inhibition of a mammary tumor during infection?
    Abello-Cáceres P; Pizarro-Bauerle J; Rosas C; Maldonado I; Aguilar-Guzmán L; González C; Ramírez G; Ferreira J; Ferreira A
    BMC Cancer; 2016 Sep; 16(1):731. PubMed ID: 27619675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin.
    Valck C; Ramírez G; López N; Ribeiro CH; Maldonado I; Sánchez G; Ferreira VP; Schwaeble W; Ferreira A
    Mol Immunol; 2010 Apr; 47(7-8):1516-21. PubMed ID: 20153898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous Calreticulin, incorporated onto non-infective Trypanosoma cruzi epimastigotes, promotes their internalization into mammal host cells.
    Sosoniuk-Roche E; Vallejos G; Aguilar-Guzmán L; Pizarro-Bäuerle J; Weinberger K; Rosas C; Valck C; Michalak M; Ferreira A
    Immunobiology; 2017 Mar; 222(3):529-535. PubMed ID: 27839837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi Calreticulin Topographical Variations in Parasites Infecting Murine Macrophages.
    González A; Valck C; Sánchez G; Härtel S; Mansilla J; Ramírez G; Fernández MS; Arias JL; Galanti N; Ferreira A
    Am J Trop Med Hyg; 2015 May; 92(5):887-97. PubMed ID: 25758653
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ramírez-Toloza G; Ferreira A
    Front Microbiol; 2017; 8():1667. PubMed ID: 28919885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin.
    López NC; Valck C; Ramírez G; Rodríguez M; Ribeiro C; Orellana J; Maldonado I; Albini A; Anacona D; Lemus D; Aguilar L; Schwaeble W; Ferreira A
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e730. PubMed ID: 20625551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.
    Sánchez-Valdéz FJ; Pérez Brandán C; Ramírez G; Uncos AD; Zago MP; Cimino RO; Cardozo RM; Marco JD; Ferreira A; Basombrío MÁ
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2696. PubMed ID: 24551259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi carrying a monoallelic deletion of the calreticulin (TcCRT) gene are susceptible to complement mediated killing and defective in their metacyclogenesis.
    Sánchez Valdéz FJ; Pérez Brandán C; Zago MP; Labriola C; Ferreira A; Basombrío MÁ
    Mol Immunol; 2013 Mar; 53(3):198-205. PubMed ID: 22954747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural bases that underline Trypanosoma cruzi calreticulin proinfective, antiangiogenic and antitumor properties.
    Peña Álvarez J; Teneb J; Maldonado I; Weinberger K; Rosas C; Lemus D; Valck C; Olivera-Nappa Á; Asenjo JA; Ferreira A
    Immunobiology; 2020 Jan; 225(1):151863. PubMed ID: 31732192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma carassii calreticulin binds host complement component C1q and inhibits classical complement pathway-mediated lysis.
    Oladiran A; Belosevic M
    Dev Comp Immunol; 2010 Apr; 34(4):396-405. PubMed ID: 19913050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Trypanosoma cruzi calreticulin in the host-parasite interplay.
    Ramírez G; Valck C; Ferreira VP; López N; Ferreira A
    Trends Parasitol; 2011 Mar; 27(3):115-22. PubMed ID: 21288773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human survivin and Trypanosoma cruzi calreticulin act in synergy against a murine melanoma in vivo.
    Aguilar-Guzmán L; Lobos-González L; Rosas C; Vallejos G; Falcón C; Sosoniuk E; Coddou F; Leyton L; Lemus D; Quest AF; Ferreira A
    PLoS One; 2014; 9(4):e95457. PubMed ID: 24755644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vivo antiangiogenic effects of calreticulin from Trypanosoma cruzi and Homo sapiens sapiens.
    Toledo V; Ramírez G; Valck C; López N; Ribeiro CH; Maldonado I; Aguilar L; Lemus D; Ferreira A
    Biol Res; 2010; 43(3):287-9. PubMed ID: 21249299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Trypanosoma cruzi calreticulin in parasite-host interactions and in tumor growth.
    Ramírez G; Valck C; Aguilar L; Kemmerling U; López-Muñoz R; Cabrera G; Morello A; Ferreira J; Maya JD; Galanti N; Ferreira A
    Mol Immunol; 2012 Oct; 52(3-4):133-40. PubMed ID: 22673211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.